Cost Recovery Implementation Statement 2021–2022
This document describes the processes to determine fees for application to provide medicines subsidised by the Pharmaceutical Benefits Scheme, and outlines the current and forecasted financial performance of the process.
Downloads
Cost Recovery Implementation Statement 2021–2022
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Publication date:
25 November 2021
Publication type:
Report
Intended audience:
Health sector